A Study to Evaluate Solriktug in Adult Participants With Asthma (RAINIER)
view all Clinical Trials
Overview
Phase 2 study to evaluate the safety, tolerability, PK, immunogenicity, and pharmacodynamics of solriktug with adult participants with asthma.
Contact
For more information about this trial or to inquire about eligibility, email [email protected] or call 215-707-1359.